Friday, 16 Feb 2018

You are here

Nailfold Capillaroscopy Portends Prognosis in Systemic Sclerosis

Two reports underscore the importance of nailfold capillaroscopy (NFC) in scleroderma and have shown that nailfold capillary drop out was significantly associated with mortality in systemic sclerosis.

A study of 99 patients from the  South Australian Scleroderma Register (SASR) followed patients from 1991 to 2015. The cohort included 99 patients with limited cutaneous SSc, 30 patients with diffuse cutaneous SSc and 23 with an overlap scleroderma syndrome. Overall there were 56 deaths. 

Diffuse scleroderma had significantly greater capillary drop out compared with limited and overlap scleroderma (p<0.001). Both capillary drop out scores and antibody status were associated with mortality.

Another study from Brazil extensively studied 170 SSc patients with high-resolution computed tomography, pulmonary function tests, and Doppler echocardiography and NFC with an avascular score.  After a  mean of 10 years, 73 patients died. (Citation source https://buff.ly/2nIvHQW)

NFC avascular score was significantly associated with mortality (HR 1.64, p = 0.001). The NFC association with mortality was was stronger than that of race, gender, anticentromere antibodies, anti-topoisomerase I antibodies, form of disease, but had similar strength to the overall skin score in univariate analyses.

Capillary loss was associated with higher risk of death and be a useful tool in prognostic evaluation of SSc.   

Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

Poor Prognosis of the MDA-5 Antibody in Dermatomyositis

Researchers from Hong Kong assessed the clinical associations seen with the anti-melanoma differentiation-associated gene 5 antibody (anti-MDA5 Ab) assay in consecutive patients with dermatomyositis (DM) and polymyositis (PM).

Twenty patients with either DM or PM who were followed in the Rheumatology Clinic of Kwong Wah Hospital, Hong Kong were recruited and underwent testing for the anti-MDA-5 antibody.

Inefficacy of Immunosuppressive Treatments in Systemic Sclerosis with ILD

EUSTAR study results published in Arthritis Research & Therapy show the current state of immunosuppressive use in systemic sclerosis patients with interstitial lung disease (SSc-ILD) to be ill-defined, but that liberal use of glucocorticoids (GC) in SSc-ILD should be discouraged.

ESRD Death Declines in Vasculitis Patients

 

In the past 2 decades, mortality from end-stage renal disease (ESRD) among U.S. patients with granulomatosis with polyangiitis (GPA) has declined significantly, a nationwide study found.

Stroke Risk Confirmed in SLE

The most common cerebrovascular events (CVEs) seen among a large cohort of patients with systemic lupus erythematosus (SLE) were stroke and transient ischemia, and the majority of these events were attributable to the disease itself, a multinational study determined.

Stem Cell Transplant Succeeds in Scleroderma

Myeloablative autologous stem cell transplantation was significantly more effective than 12 months of cyclophosphamide among patients with severe scleroderma, an open-label multicenter study found.